In 2023, the share of French scientific publications in the top 10% of cited publications in infectious diseases was part of the baseline leading into forecasted data from 2024. From 2024 to 2028, France's share is projected to grow incrementally from 10.2% to 10.23%, signifying a stable presence in high-impact research within this domain. The year-on-year increases are almost negligible, reflecting a steady but slight upward trend. Between 2024 and 2028, the compound annual growth rate (CAGR) is minimal, underscoring consistency rather than substantial growth over this period.
Future trends to watch for include potential shifts in global research priorities, increased international collaboration, and technological advancements that could influence the share of top-cited publications. Keeping an eye on funding changes and policy adjustments within the European Union, particularly in science and research, could also impact these dynamics.
